首页 › 股票 › EVMN

EVMN — EVOMMUNE INC

申报持仓市值$555.06M
持有基金数(最新)151
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)111
机构持仓市值$466.41M · 36.82M 股
新建/增持/减仓/清仓46 / 37 / 13 / 21 · 更新于 2026-11-14
前五大/前十大集中度41.1% / 60.9%
机构整体持仓变动 增持 +15.5% (+4.37M 股)
机构持仓市值变动 下降 -34.0%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 111 家机构在其最新 13F 申报中持有 EVMN(EVOMMUNE INC),合计申报市值 $466.41M,对应 36.82M 股。按股数计算较上季度增持 15.5%(+4.37M 股),申报市值环比下降 34.0%。持仓集中度较高:前五大持有人占申报市值的 41.1%,前十大的集中度为 60.9%。

与上一季度相比,46 家新建仓位、37 家加仓、13 家减仓、21 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

EVOMMUNE INC(EVMN)的主要机构持有人包括 RA CAPITAL MANAGEMENT, L.P.、EQT Fund Management S.a r.l.、MPM BioImpact LLC,按 13F 申报市值在本页 151 家持有人中排名居前。

EVMN 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 63 16.56M $136.80M -4.6%
Q2 2026 111 36.82M $466.41M +15.5%
Q1 2026 86 35.79M $795.62M +17.5%
Q4 2025 60 28.05M $466.77M —

表内 4 个季度中,机构持股合计减少 41%(Q4 2025 → Q3 2026);单季变动最大的是 Q1 2026(+17.5%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
EQT Fund Management S.a r.l. 历史持仓 5.29M $43.68M 4.61% 持有
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.93M $15.92M 6.49% 持有
Nan Fung Group Holdings Ltd 历史持仓 1.44M $11.90M 8.04% 持有
BlackRock Inc 1.15M $9.53M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 1.00M $8.30M 0.00% 增持
AMERICAN CENTURY COMPANIES INC 762.34K $6.30M 0.00% 增持
Qube Research & Technologies Ltd 684.71K $5.66M 0.01% 增持
SILVERARC CAPITAL MANAGEMENT, LLC 历史持仓 594.03K $4.91M 0.62% 新进
BARCLAYS PLC 526.56K $4.35M 0.01% 增持
Geode Capital Management 467.27K $3.86M 0.00% 增持
JANE STREET GROUP, LLC 330.03K $2.73M 0.00% 增持
STATE STREET CORP 267.91K $2.21M 0.00% 增持
BNP PARIBAS FINANCIAL MARKETS 243.51K $2.01M 0.00% 增持
Fidelity Management & Research (FMR) 168.77K $1.39M 0.00% 增持
Y-Intercept (Hong Kong) Ltd 158.81K $1.31M 0.03% 增持
Nuveen, LLC 158.16K $1.31M 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 152.82K $1.26M 0.00% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 136.26K $1.13M 0.00% 增持
HRT FINANCIAL LP 127.31K $1.05M 0.00% 新进
NEXTBio Capital Management LP 历史持仓 119.06K $983.46K 0.43% 持有
Andera Partners 历史持仓 97.36K $804.21K 0.46% 减持
Morgan Stanley 94.57K $781.17K 0.00% 减持
Jump Financial, LLC 84.02K $694.03K 0.01% 增持
Squarepoint Ops LLC 79.70K $658.29K 0.00% 增持
Walleye Capital LLC 78.97K $652.27K 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
EQT Fund Management S.a r.l. 历史持仓 5.29M $70.28M 8.15% 增持
RA CAPITAL MANAGEMENT, L.P. 历史持仓 3.49M $46.44M 0.40% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 1.94M $25.80M 0.00% 增持
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.93M $25.61M 8.32% 持有
JPMorgan Chase & Co 1.55M $23.37M 0.00% 增持
RTW INVESTMENTS, LP 1.50M $19.96M 0.17% 持有
Nan Fung Group Holdings Ltd 历史持仓 1.44M $19.15M 14.56% 持有
Point72 Asset Management 1.44M $19.07M 0.07% 增持
Andera Partners 历史持仓 1.39M $18.50M 8.96% 减持
EVENTIDE ASSET MANAGEMENT, LLC 1.21M $16.07M 0.21% 持有
Vestal Point Capital, LP 1.00M $13.29M 0.31% 新进
Jupiter Topco LLC 896.70K $11.92M 0.01% 新进
BlackRock Inc 886.54K $11.78M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 881.89K $11.72M 0.00% 增持
BAKER BROS. ADVISORS LP 847.39K $11.26M 0.06% 持有
Defilade Capital Management, L.P. 历史持仓 793.14K $10.54M 1.41% 增持
AMERICAN CENTURY COMPANIES INC 755.02K $10.03M 0.00% 增持
Alyeska Investment Group, L.P. 704.42K $9.36M 0.02% 减持
Affinity Asset Advisors, LLC 500.10K $6.65M 0.32% 新进
Velan Capital Investment Management LP 历史持仓 451.25K $6.00M 3.84% 增持
UBS Group AG 413.55K $5.50M 0.00% 增持
FEDERATED HERMES, INC. 325.00K $4.32M 0.01% 持有
GREAT POINT PARTNERS LLC 历史持仓 325.00K $4.32M 0.91% 持有
Freestone Grove Partners LP 306.33K $4.07M 0.03% 减持
GEODE CAPITAL MANAGEMENT, LLC 301.76K $4.01M 0.00% 新进

Q1 2026 — 25 家基金

基金股数金额组合权重变化
EQT Fund Management S.a r.l. 历史持仓 4.93M $113.33M 11.10% 持有
RA CAPITAL MANAGEMENT, L.P. 历史持仓 3.49M $80.34M 0.85% 增持
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.93M $44.30M 15.83% 持有
Andera Partners 历史持仓 1.90M $43.62M 24.66% 持有
RTW INVESTMENTS, LP 1.50M $34.54M 0.34% 增持
MPM BioImpact LLC 1.46M $33.47M 2.58% 增持
Nan Fung Group Holdings Ltd 历史持仓 1.44M $33.13M 27.32% 持有
JPMorgan Chase & Co 1.46M $32.11M 0.00% 增持
SymBiosis Capital Partners, LLC 历史持仓 1.28M $29.45M 55.80% 持有
EVENTIDE ASSET MANAGEMENT, LLC 1.21M $27.80M 0.46% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 1.12M $25.73M 0.00% 增持
Janus Henderson Group 896.70K $20.62M 0.01% 新进
Marshall Wace 879.73K $20.22M 0.03% 减持
BAKER BROS. ADVISORS LP 847.39K $19.48M 0.12% 新进
Alyeska Investment Group, L.P. 726.36K $16.70M 0.05% 新进
Defilade Capital Management, L.P. 历史持仓 678.59K $15.60M 2.19% 增持
BlackRock Inc 673.57K $15.49M 0.00% 增持
Kynam Capital Management, LP 625.50K $14.38M 0.93% 增持
SECTORAL ASSET MANAGEMENT INC 589.00K $13.54M 11.22% 持有
Verition Fund Management LLC 549.99K $12.64M 0.17% 减持
AMERICAN CENTURY COMPANIES INC 492.94K $11.33M 0.01% 增持
VANGUARD CAPITAL MANAGEMENT LLC 455.05K $10.46M 0.00% 新进
PERCEPTIVE ADVISORS LLC 448.35K $10.31M 0.22% 新进
Velan Capital Investment Management LP 历史持仓 446.25K $10.26M 6.43% 减持
Freestone Grove Partners LP 337.29K $7.75M 0.06% 新进

Q4 2025 — 25 家基金

基金股数金额组合权重变化
EQT Fund Management S.a r.l. 历史持仓 4.93M $84.40M 7.59% 新进
RA CAPITAL MANAGEMENT, L.P. 历史持仓 3.46M $59.21M 0.61% 新进
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.93M $32.99M 12.75% 新进
Andera Partners 历史持仓 1.90M $32.48M 18.39% 新进
Nan Fung Group Holdings Ltd 历史持仓 1.44M $24.67M 22.08% 新进
JPMorgan Chase & Co 1.31M $22.41M 0.00% 新进
RTW INVESTMENTS, LP 1.28M $21.98M 0.22% 新进
SymBiosis Capital Partners, LLC 历史持仓 1.28M $21.93M 20.02% 新进
Marshall Wace 988.20K $16.92M 0.02% 新进
EVENTIDE ASSET MANAGEMENT, LLC 961.52K $16.46M 0.26% 新进
PRICE T ROWE ASSOCIATES INC /MD/ 782.12K $13.39M 0.00% 新进
SECTORAL ASSET MANAGEMENT INC 589.00K $10.08M 8.08% 新进
Verition Fund Management LLC 565.21K $9.68M 0.09% 新进
Aberdeen Group plc 525.38K $8.99M 0.01% 新进
Velan Capital Investment Management LP 历史持仓 506.75K $8.68M 5.11% 新进
Vanguard Group 502.57K $8.60M 0.00% 新进
Octagon Capital Advisors LP 500.00K $8.56M 1.04% 新进
AMERICAN CENTURY COMPANIES INC 417.45K $7.15M 0.00% 新进
FEDERATED HERMES, INC. 325.00K $5.56M 0.01% 新进
GREAT POINT PARTNERS LLC 历史持仓 325.00K $5.56M 1.80% 新进
NEXTBio Capital Management LP 历史持仓 228.29K $3.91M 2.29% 新进
Defilade Capital Management, L.P. 历史持仓 215.42K $3.69M 0.50% 新进
Kynam Capital Management, LP 185.48K $3.18M 0.21% 新进
ADAR1 Capital Management, LLC 184.06K $3.15M 0.24% 新进
Monashee Investment Management LLC 183.24K $3.14M 1.80% 新进

查看全部 151 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025
EQT Fund Management S.a r.l. 5.29M 5.29M 4.93M 4.93M
Pivotal bioVenture Partners Investment Advisor LLC 1.93M 1.93M 1.93M 1.93M
Nan Fung Group Holdings Ltd 1.44M 1.44M 1.44M 1.44M
BlackRock Inc 1.15M 886.54K 673.57K 142.44K
VANGUARD CAPITAL MANAGEMENT LLC 1.00M 881.89K 455.05K —
AMERICAN CENTURY COMPANIES INC 762.34K 755.02K 492.94K 417.45K
Qube Research & Technologies Ltd 684.71K 30.11K — 24.06K
SILVERARC CAPITAL MANAGEMENT, LLC 594.03K — — —
BARCLAYS PLC 526.56K 178.73K 1.98K —
Geode Capital Management 467.27K 301.76K 248.61K 109.78K
JANE STREET GROUP, LLC 330.03K 29.20K — —
STATE STREET CORP 267.91K — 179.51K 31.50K
BNP PARIBAS FINANCIAL MARKETS 243.51K 133.35K 2.20K —
Fidelity Management & Research (FMR) 168.77K 164 1.72K —
Y-Intercept (Hong Kong) Ltd 158.81K 28.40K — —
Nuveen, LLC 158.16K 20.90K 12.45K —
VANGUARD FIDUCIARY TRUST CO 152.82K 88.20K 72.58K —
VANGUARD PORTFOLIO MANAGEMENT LLC 136.26K 119.93K 60.99K —
HRT FINANCIAL LP 127.31K — — —
NEXTBio Capital Management LP 119.06K 119.06K 184.06K 228.29K

下载持有人名单 (CSV)

常见问题

Which funds hold EVMN?

As of 2026-Q2, 111 institutional funds reported holding EVMN (EVOMMUNE INC) in SEC 13F filings, with a combined reported value of $466.41M.

How many shares of EVMN do institutions own?

13F filers reported 36.82M shares of EVMN, worth $466.41M in aggregate at the end of 2026-Q2.

Is institutional ownership of EVMN rising or falling?

Share counts moved +15.5% versus the prior quarter — accumulation.

Who are the top institutional holders of EVMN?

The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., MPM BioImpact LLC, SymBiosis Capital Partners, LLC, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.

Who are the major shareholders of EVOMMUNE INC?

The major shareholders of EVOMMUNE INC (EVMN) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., MPM BioImpact LLC, SymBiosis Capital Partners, LLC, PRICE T ROWE ASSOCIATES INC /MD/, among 151 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 EVMN」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/EVMN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →